4SA.F ACOUSORT AB O.N.
- Market cap
- EUR 5.14M
- P/E
- -
- P/B
- 5.98x
- ROE
- -120.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 4SA.F undervalued?
Graham numberThe Graham number of ACOUSORT AB O.N. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ACOUSORT AB O.N. fundamental analysis
No fundamental analysis for ACOUSORT AB O.N. yet.
ACOUSORT AB O.N. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ACOUSORT AB O.N.
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separati…
Full company profileACOUSORT AB O.N. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
ACOUSORT AB O.N. annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 3.01M | 4.96M | 5.53M | 4.74M | 6.85M | 8.53M |
| Gross Profit | 548K | 2.91M | 3.37M | 4.77M | 6.74M | 8.14M |
| Operating Income | -12.2M | -14.3M | -17.5M | -16.1M | -10.9M | -13.3M |
| EBITDA | - | -12.8M | -16.3M | -14.1M | -10.6M | -11.7M |
| Net Income | -12.3M | -13.8M | -17.1M | -15.1M | -12.2M | -11.8M |
| EPS | -0.93 | -1.04 | -1.15 | -1.01 | -0.57 | -0.56 |
| Balance Sheet | ||||||
| Total Assets | 36.6M | 41.5M | 34.5M | 12.3M | 17.9M | 21.5M |
| Total Liabilities | 3.54M | 22.5M | 10.4M | 3.86M | 1.59M | 11.7M |
| Shareholders' Equity | 33.0M | 18.9M | 24.1M | 8.46M | 16.3M | 9.81M |
| Cash & Short-term Investments | 31.5M | 34.4M | 24.0M | 3.57M | 6.29M | 9.48M |
| Cash Flow | ||||||
| Operating Cash Flow | -11.0M | 3.97M | -31.6M | -18.8M | -16.8M | 7.93M |
| Capital Expenditure | 1.31M | 1.01M | 1.13M | 1.03M | 488K | 354K |
| Free Cash Flow | -12.3M | 2.95M | -32.7M | -19.8M | -17.3M | 7.58M |
| Ratios | ||||||
| ROE | -37.2% | -72.7% | -70.8% | -178.2% | -74.6% | -120.5% |
| ROA | -33.6% | -33.2% | -49.5% | -122.3% | -67.9% | -55.0% |
| Net Profit Margin | -408.2% | -277.7% | -308.8% | -318.3% | -177.3% | -138.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ACOUSORT AB O.N. dividends
ACOUSORT AB O.N. has not paid dividends in the last 5 fiscal years.
Who owns ACOUSORT AB O.N.
- Insiders 29.32%
- Institutions 16.86%
- Public & others 53.83%
- Shares outstanding 21.2M
- Free float 15.8M
ACOUSORT AB O.N. company profile
- Company name
- ACOUSORT AB O.N.
- Ticker
- 4SA.F
- ISIN
- SE0009189608
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 11
- Fiscal year end
- December
- Address
- Building 406, Lund, Sweden, 223 81
- Phone
- 46 45 20 45 08 54
- Website
- acousort.com
About ACOUSORT AB O.N.
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a microfluidic cell sorters or quality control systems for bioreactors and cell therapy production; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has a collaboration agreement with Moeller Medical to exhibit a prototype system for analyzing separation of cells from body fluids. AcouSort AB (publ) was incorporated in 2010 and is based in Lund, Sweden.
ACOUSORT AB O.N. management
6- Mr. Torsten Freltoft M.Sc., Ph.D.Chief Executive Officer · born 1958
- Prof. Thomas Laurell Ph.D.Founder & Independent Director · born 1961
- Dr. Stefan Scheding M.D.Founder & Independent Director · born 1962
- Prof. Patrik Brundin M.D., Ph.D.Founder
- Dr. Hans LiljaFounder
- Mr. Gunnar TelhammarChief Financial Officer · born 1961